Lupin Signs ADHD Drugs Deal With Aytu In Canada
Local Registration And Authorizations Expected Over The Next 18-To-24 Months
Lupin has added two ADHD drugs to its Canadian portfolio, while also signing multiple branded deals in other global markets.
Lupin has added two ADHD drugs to its Canadian portfolio, while also signing multiple branded deals in other global markets.